Search Results 1711-1720 of 18444 for ectopic-pregnancy

1. Obstetrics and Gynecology - Doctors - Mayo Clinic

   ... tubal patency testing, Deferred reproduction, Infertility, Double uterus, Primary ovarian insufficiency, Hypothyroidism, Amenorrhea, Uterine anomaly ...

2. Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III - Mayo Clinic

   Positive pregnancy test (all female subjects of childbearing potential must have a urine β-human chorionic gonadotropin [hCG] pregnancy test performed at ...

3. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... pregnancy test (β human chorionic gonadotropin [β-hCG]). When a woman is of childbearing potential the following are required: Subject must agree to ...

4. Evaluation Of Peripheral Nerve Stimulation For Acute Treatment Of Migraine Pain - Mayo Clinic

   ... pregnant or breastfeeding, pregnant within the past 6 months or intends to become pregnant during the enrollment period - Diagnosis of chronic migraine or ...

5. A Study of Paclitaxel with or without Cixutumumab as Second-Line Therapy for Treating Patients with Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer - Mayo Clinic

   ... pregnancy; Females of child-bearing potential and men must agree to use adequate contraception (hormonal, barrier method or birth control, or abstinence) for ...

6. A Study of a Stem Cell Fistula Plug to Treat Cryptoglandular Perianal Fistulas - Mayo Clinic

   Pregnant patients or trying to become pregnant; Non-enterocutaneous tracts (i.e. recto-vaginal, entero-vesicular); Multi-tract, suprasphincteric and ...

7. A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician’s choice chemotherapy, for the treatment of participants with metastatic HER2-positive breast cancer - Mayo Clinic

   Female participants who are breastfeeding or pregnant, and female and male participants planning a pregnancy. Note: Other protocol defined Inclusion ...

8. A Study of Catequentinib, Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma - Mayo Clinic

   Females of childbearing potential must have a negative pregnancy test (by serum betaHCG) within 7 days prior to the start of treatment. Female of ...

9. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   A WOCBP must have a negative highly sensitive serum pregnancy test (as ... pregnant. All prior treatment-related toxicities (defined by National Cancer ...

10. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors - Mayo Clinic

    Have a negative pregnancy test (if female of childbearing potential). Have acceptable liver function: Bilirubin ≤ 1.5× upper limit of normal (ULN);.